Skip to main content
main-content

Zeitschrift

Breast Cancer Research

Breast Cancer Research 5/2007

Ausgabe 5/2007

Inhaltsverzeichnis ( 23 Artikel )

01.10.2007 | Review | Ausgabe 5/2007

Breast cancer risk-assessment models

D Gareth R Evans, Anthony Howell

01.10.2007 | Commentary | Ausgabe 5/2007

Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer

Erica L Mayer, Lisa A Carey, Harold J Burstein

01.10.2007 | Commentary | Ausgabe 5/2007

Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer

Alexandra F Leary, Bhawna Sirohi, Stephen RD Johnston

01.10.2007 | Research article | Ausgabe 5/2007 Open Access

Role of human HGFIN/nmbin breast cancer

Rebecca L Metz, Prem S Patel, Meera Hameed, Margaret Bryan, Pranela Rameshwar

01.10.2007 | Research article | Ausgabe 5/2007 Open Access

Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers

Christina Yau, Vita Fedele, Ritu Roydasgupta, Jane Fridlyand, Alan Hubbard, Joe W Gray, Karen Chew, Shanaz H Dairkee, Dan H Moore, Francesco Schittulli, Stefania Tommasi, Angelo Paradiso, Donna G Albertson, Christopher C Benz

01.10.2007 | Research article | Ausgabe 5/2007 Open Access

BP1 transcriptionally activates bcl-2and inhibits TNFα-induced cell death in MCF7 breast cancer cells

Holly S Stevenson, Sidney W Fu, Joseph J Pinzone, Jinguen Rheey, Samuel J Simmens, Patricia E Berg

01.10.2007 | Research article | Ausgabe 5/2007 Open Access

Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy

Anna L Stratford, Golareh Habibi, Arezoo Astanehe, Helen Jiang, Kaiji Hu, Eugene Park, Ashleen Shadeo, Timon PH Buys, Wan Lam, Trevor Pugh, Marco Marra, Torsten O Nielsen, Uwe Klinge, Peter R Mertens, Samuel Aparicio, Sandra E Dunn

01.10.2007 | Research article | Ausgabe 5/2007 Open Access

Recent changes in breast cancer incidence and risk factor prevalence in San Francisco Bay area and California women: 1988 to 2004

Theresa HM Keegan, Ellen T Chang, Esther M John, Pamela L Horn-Ross, Margaret R Wrensch, Sally L Glaser, Christina A Clarke

01.10.2007 | Research article | Ausgabe 5/2007 Open Access

Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation

Thomas Schlange, Yutaka Matsuda, Susanne Lienhard, Alexandre Huber, Nancy E Hynes

01.10.2007 | Research article | Ausgabe 5/2007 Open Access

Comparison of different commercial kits for HER2 testing in breast cancer: looking for the accurate cutoff for amplification

Anne Cayre, Florence Mishellany, Nicole Lagarde, Frédérique Penault-Llorca

01.10.2007 | Research article | Ausgabe 5/2007 Open Access

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

Bas Kreike, Marieke van Kouwenhove, Hugo Horlings, Britta Weigelt, Hans Peterse, Harry Bartelink, Marc J van de Vijver

01.10.2007 | Research article | Ausgabe 5/2007 Open Access

A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer

Heidi Schwarzenbach, Volkmar Müller, Cord Beeger, Miriam Gottberg, Nicole Stahmann, Klaus Pantel

01.10.2007 | Commentary | Ausgabe 5/2007

Transphosphorylation of kinase-dead HER3 and breast cancer progression: a new standpoint or an old concept revisited?

Javier A Menendez, Ruth Lupu

01.10.2007 | Review | Ausgabe 5/2007

P-cadherin expression in breast cancer: a review

Joana Paredes, Ana Luísa Correia, Ana Sofia Ribeiro, André Albergaria, Fernanda Milanezi, Fernando C Schmitt

01.10.2007 | Research article | Ausgabe 5/2007 Open Access

Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion

Deborah L Holliday, Simon Hughes, Jacqueline A Shaw, Rosemary A Walker, J Louise Jones

01.10.2007 | Research article | Ausgabe 5/2007 Open Access

Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study

Marc van de Vijver, Michael Bilous, Wedad Hanna, Manfred Hofmann, Petra Kristel, Frédérique Penault-Llorca, Josef Rüschoff

01.10.2007 | Research article | Ausgabe 5/2007 Open Access

Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling

Ana Quaglino, Carolina Schere-Levy, Leonardo Romorini, Roberto P Meiss, Edith C Kordon

01.10.2007 | Research article | Ausgabe 5/2007 Open Access

Efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis

Jos A van der Hage, J Sven D Mieog, Marc J van de Vijver, Cornelis JH van de Velde, cooperating investigators of the European Organization for Research and Treatment of Cancer

01.10.2007 | Viewpoint | Ausgabe 5/2007

Live or let die: oestrogen regulation of survival signalling in endocrine response

Alison J Butt, Robert L Sutherland, Elizabeth A Musgrove

01.10.2007 | Research article | Ausgabe 5/2007 Open Access

Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53codon 72 Arg>Pro polymorphism

Sailesh Gochhait, Syed Irfan Ahmad Bukhari, Narendra Bairwa, Shivani Vadhera, Katayoon Darvishi, Mohammad Raish, Pawan Gupta, Syed Akhtar Husain, Rameshwar NK Bamezai

01.10.2007 | Research article | Ausgabe 5/2007 Open Access

Dietary intake and breast density in high-risk women: a cross-sectional study

Marilyn Tseng, Celia Byrne, Kathryn A Evers, Mary B Daly

01.10.2007 | Research article | Ausgabe 5/2007 Open Access

Different measures of smoking exposure and mammographic density in postmenopausal Norwegian women: a cross-sectional study

Yngve Bremnes, Giske Ursin, Nils Bjurstam, Inger T Gram

01.10.2007 | Research article | Ausgabe 5/2007 Open Access

Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status

Tanja Fehm, Sven Becker, Silke Duerr-Stoerzer, Karl Sotlar, Volkmar Mueller, Diethelm Wallwiener, Nancy Lane, Erich Solomayer, Jonathan Uhr

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise